ArticleJournal of clinical medicine2024

Risk of Hepatitis B Virus Reactivation in COVID-19 Patients Receiving Immunosuppressive Treatment: A Prospective Study.

Nicoleta Mihai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.